- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
McGee steps down at Serviscope
Robert McGee has resigned as president and CEO of asset managementfirm Serviscope of Wallingford, CT, as part of a restructuringof the company's management. The company declined to give a reasonfor the changes, although it did say that McGee will
Robert McGee has resigned as president and CEO of asset managementfirm Serviscope of Wallingford, CT, as part of a restructuringof the company's management. The company declined to give a reasonfor the changes, although it did say that McGee will continueto work with the company as a consultant on new business and strategicdevelopment.
Former vice president of field operations Robert Cate has takenMcGee's position as president, and also adds COO to his title.The company also formed an executive management committee thatincludes Cate and four other executives.
Serviscope said the reorganization was necessary to enhancethe company's growth, which has resulted from its expansion intoasset management. Serviscope expects to post revenues of $25 millionthis year, compared with $13 million in 1995, and the firm hasa backlog of $64 million.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
